“…However, currently C. africana is known as a biovariant of C. albicans with an exceptional capacity to colonize human genitalia and cause mainly vaginal infections (Romeo and Criseo, 2011; Romeo et al, 2013). Its distribution appears to be worldwide, with cases of infection reported from China (Shan et al, 2014; Hu et al, 2015), Japan (Odds et al, 2007), South Korea (Song et al, 2014), Colombia (Rodríguez-Leguizamón et al, 2015), Argentina (Theill et al, 2016), Chile (Odds et al, 2007), India (Sharma et al, 2014), Iran (Yazdanparast et al, 2015), Africa (Tietz et al, 2001; Dieng et al, 2012; Nnadi et al, 2012; Ngouana et al, 2015), USA (Romeo et al, 2013), and Europe (Alonso-Vargas et al, 2008; Romeo and Criseo, 2009; Borman et al, 2013). However, despite the efforts made so far, it is rather difficult to discriminate C. africana from C. albicans in clinical diagnostic laboratories and therefore its epidemiology is still unclear and needs more investigation (Romeo et al, 2013).…”